Status:
COMPLETED
Clinical Study to Evaluate the Efficacy of an Anti-Fungal Supplement
Lead Sponsor:
CanXida
Collaborating Sponsors:
Citruslabs
Conditions:
Candida Systemic
Candida Albicans Infection
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
This is a virtual, double-blind, two-arm, randomized, placebo-controlled clinical trial that will last 12 weeks. Participants will take the CanXida Remove Candida Cleansing Formula RMV or a placebo pr...
Eligibility Criteria
Inclusion
- Aged between 18-50.
- Female.
- Self-reported recurrent vaginal issues, including:
- Itching and irritation in and around the vaginal area.
- Burning sensation during urination or sexual intercourse.
- Abnormal discharge (e.g. thicker, white, and curd-like in appearance, odorless, or with a mild yeasty smell.
- Redness and swelling of the vulva and surrounding skin
- Pain or discomfort in the vaginal area or lower abdomen.
- Urinary tract infections
- Vaginal thrush
- May also experience issues with fatigue, lethargy, and gut or digestive issues.
- Willing to provide two stool samples during the study.
- Willing to adhere to the study protocol.
- Willing to avoid introducing any products or any new forms of regular medication or supplements that target candida overgrowth, gut health, or vaginal health for the duration of the study.
Exclusion
- Anyone with severe chronic conditions including oncological conditions, psychiatric disease, diabetes, or other.
- Anyone with known severe allergic reactions or is allergic to the test product or placebo ingredients.
- Currently taking any antibiotics or will be during the trial period.
- Anymore diagnosed with a sexually transmitted disease within the last three months e.g. Chlamydia, trichomoniasis, gonorrhea, genital herpes
- Women who are pregnant, breastfeeding, or attempting to become pregnant.
- Having any planned invasive medical procedures during the study period.
- Currently participating in any other clinical study.
- History of substance abuse.
- Unwilling to follow the study protocol.
Key Trial Info
Start Date :
November 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 28 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06146504
Start Date
November 30 2023
End Date
June 28 2024
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Citruslabs
Santa Monica, California, United States, 90404